Chinese oil refiner Hengli Petrochemical faces U.S. allegations of funding Iran's government through purchases of sanctioned Iranian crude oil. The company, one of China's largest independent refiners, allegedly structured transactions to obscure the origin of oil shipments and bypass American sanctions regimes.

U.S. officials contend Hengli knowingly purchased Iranian crude at discounted prices through intermediaries and shell companies, funneling revenue to Tehran's government in violation of secondary sanctions. These sanctions prohibit non-U.S. entities from conducting significant transactions with Iran's oil sector. The transactions reportedly involved transshipment operations that concealed Iranian provenance.

Hengli operates one of Asia's largest private refineries with significant crude processing capacity. The company's refining operations consume roughly 400,000 barrels daily, making it a substantial player in global oil flows. Accusations of Iranian oil purchases could trigger enforcement action against the refiner and potentially restrict its access to U.S. dollar settlement systems and Western financial markets.

The allegations emerge amid intensifying U.S. efforts to enforce Iran sanctions following the 2018 withdrawal from the nuclear agreement. American authorities have pursued multiple Chinese refiners and trading companies for similar violations. Previous cases resulted in hefty fines and operational restrictions.

For oil markets, the investigation adds pressure on crude prices by potentially constraining demand from major Asian refiners. It also underscores growing friction between U.S. sanctions enforcement and Chinese independent refiners' cost-cutting purchasing practices. Hengli's reliance on discounted Iranian barrels reflects competitive pressures within China's refining sector, where margins remain thin.

The company has not publicly responded to the allegations. Resolution could involve substantial penalties, compliance overhaul, or operational changes affecting its crude sourcing strategy. Chinese regulators have historically resisted U.S. secondary sanctions, complicating enforcement.